A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

Clinical trial NCT07532226 · RECRUITING

Trial details

NCT number: NCT07532226
Sponsor: Janssen-Cilag Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Arthritis, Psoriatic

Start date: 2026-04-17
Primary completion: 2029-12-10
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.